Remus Pharmaceuticals Limited

REMUSNSE · IN

Holders

REDUCEDT+30
Blue Lotus Capital Multi Bagger Fund II
Remus Pharmaceuticals Limited · NSE
−63,900 sh · ₹5.30 Cr
Filed 7 Aug 2026NSE bulk dealview source
ACQUIREDStale
Alkaben Dipakkumar Shah
Remus Pharmaceuticals Limited · NSE
+2,600 sh · ₹18.42 L
Filed 12 Jan 2026SEBI Reg 7view source
ACQUIREDStale
Arpit Deepakkumar Shah
Remus Pharmaceuticals Limited · NSE
+1,200 sh · ₹8.85 L
Filed 29 Dec 2025SEBI Reg 7view source
ACQUIREDStale
Renosen Pharmaceuticals Private Limited
Remus Pharmaceuticals Limited · NSE
+500 sh · ₹3.76 L
Filed 23 Dec 2025SEBI Reg 7view source
ACQUIREDStale
Dhruvalben V Shah
Remus Pharmaceuticals Limited · NSE
+500 sh · ₹3.61 L
Filed 15 Dec 2025SEBI Reg 7view source
ACQUIREDStale
Vinodkumar Gandalal Shah
Remus Pharmaceuticals Limited · NSE
+500 sh · ₹3.62 L
Filed 12 Dec 2025SEBI Reg 7view source
ACQUIREDStale
Renosen Pharmaceuticals Private Limited
Remus Pharmaceuticals Limited · NSE
+200 sh · ₹1.46 L
Filed 1 Oct 2025SEBI Reg 7view source
ACQUIREDStale
Roma Vinodbhai Shah
Remus Pharmaceuticals Limited · NSE
+3,000 sh · ₹24.00 L
Filed 23 Sept 2025SEBI Reg 7view source
ACQUIREDStale
Dhruvalben V Shah
Remus Pharmaceuticals Limited · NSE
+200 sh · ₹1.71 L
Filed 13 Aug 2025SEBI Reg 7view source